Physician profile
John Matthews
NPI 1437647351
$2,136.53
in general payments reported to CMS, 2019-2025
6 companies · $366 in 2025
The $366 reported for 2025 was less than what a typical Adult Reconstructive Orthopaedic Surgery provider received nationally (typical 2025 total: $1,425).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $82.62 · 2023: $1,435 · 2024: $253 · 2025: $366.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,552 · Travel and Lodging: $502.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,551.83 |
| Travel and Lodging | $502.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,656.61 | 2022-2025 | Mako, Gamma |
| Medical Device Business Services, INC. | $171.21 | 2023 | |
| Smith+Nephew, INC. | $133.52 | 2025 | Real Intelligence |
| Overture Orthopaedics | $93.00 | 2025 | Overtureti |
| Integra Lifesciences Corporation | $54.41 | 2022 | |
| Depuy Synthes Sales INC. | $27.78 | 2024 | Motoband, Na |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Matthews listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.